A carregar...
Hepatic safety of ambrisentan alone and in combination with tadalafil: a post-hoc analysis of the AMBITION trial
Treatment with endothelin receptor antagonists (ERA) can result in adverse hepatic effects in patients with pulmonary arterial hypertension (PAH). We evaluated the hepatic safety of ambrisentan (ABS), an ERA, used as monotherapy, or with tadalafil (TAD), a phosphodiesterase-5 (PDE5) inhibitor as ini...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2018-08-01
|
| Colecção: | Pulmonary Circulation |
| Acesso em linha: | https://doi.org/10.1177/2045894018797273 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|